SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-10-005412
Filing Date
2010-02-04
Accepted
2010-02-04 16:58:26
Documents
11
Period of Report
2010-01-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v173222_8k.htm 8-K 34519
2 v173222_ex3-1.htm EX-3.1 48757
3 GRAPHIC ex3-1pg01.jpg GRAPHIC 172457
4 GRAPHIC ex3-1pg02.jpg GRAPHIC 271273
5 GRAPHIC ex3-1pg03.jpg GRAPHIC 242657
6 GRAPHIC ex3-1pg04.jpg GRAPHIC 201747
7 GRAPHIC ex3-1pg05.jpg GRAPHIC 194175
8 GRAPHIC ex3-1pg06.jpg GRAPHIC 243168
9 GRAPHIC ex3-1pg07.jpg GRAPHIC 267719
10 v173222_ex16-1.htm EX-16.1 6590
11 v173222_ex99-1.htm EX-99.1 12291
  Complete submission text file 0001144204-10-005412.txt   2300137
Mailing Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD, ZHIFU DISTRICT YANTAI, SHANDONG PROVINCE F4 264000
Business Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP NO. 9 DAXIN ROAD, ZHIFU DISTRICT YANTAI, SHANDONG PROVINCE F4 264000 86-535-6763559
Bohai Pharmaceuticals Group, Inc. (Filer) CIK: 0001443242 (see all company filings)

IRS No.: 980588402 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-53401 | Film No.: 10574748
SIC: 1040 Gold and Silver Ores